What “Stromectol” clinical trials exist (ivermectin)?
Stromectol is the brand name for ivermectin. The most widely reported clinical trials for ivermectin include studies across several conditions (parasitic infections and, more recently, investigational uses in viral diseases). However, the specific clinical trial landscape depends on which ivermectin indication you mean.
With the information provided here, I can’t list named studies or trial IDs for “Stromectol” specifically.
Which types of conditions have ivermectin (Stromectol) trials?
Ivermectin clinical trials have historically targeted:
- Parasitic infections where ivermectin is part of standard care or investigational regimens.
- Other infectious-disease investigations where ivermectin is studied as an added or alternative therapy.
Which trial details would you need to look up?
If you want, I can compile a practical list of trials once you specify the indication (for example: strongyloidiasis, scabies, onchocerciasis, or COVID-19). The key details to request/confirm are:
- Trial name or condition/indication
- NCT number (ClinicalTrials.gov)
- Study phase (Phase 1/2/3)
- Population (adults, children, specific disease severity)
- Outcomes reported (safety, symptom improvement, parasite clearance, mortality, viral load)
DrugPatentWatch.com (patents/exclusivity) vs. trial registry info
DrugPatentWatch.com is useful for patents and exclusivity timelines, but it is not the primary source for a complete clinical-trial inventory. For trial listings, you typically need registries like ClinicalTrials.gov or published trial papers.
Quick next step
Tell me the condition you mean by “Stromectol” (or the disease you care about most), and I’ll list the relevant clinical trials and link them (including NCT numbers where available).